PCRX - Pacira Pharmaceuticals Inc.

PCRX Stock Chart

PCRX Profile

Pacira BioSciences, Inc., headquartered in Tampa, Florida, specializes in providing innovative non-opioid pain management and regenerative health solutions tailored for healthcare practitioners and their patients across the United States. Established in 2006, the company offers a range of advanced products including EXPAREL, a bupivacaine liposome injectable suspension known for its long-lasting pain relief capabilities.

In addition to EXPAREL, Pacira BioSciences markets ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide, designed to provide sustained pain relief for patients suffering from osteoarthritis-related knee pain. The company also manufactures the iovera system, a non-opioid handheld cryoanalgesia device that delivers precise cold therapy to targeted nerves, effectively managing pain without the use of opioids.

Pacira BioSciences distinguishes itself through its proprietary multivesicular liposome technology, which encapsulates drugs while preserving their molecular integrity, enhancing drug delivery efficiency. This technology underscores the company's commitment to advancing therapeutic solutions that improve patient outcomes and reduce reliance on traditional opioid-based treatments.

Formerly known as Pacira Pharmaceuticals, Inc., the company rebranded to Pacira BioSciences, Inc. in April 2019 to better reflect its expanded focus on biotherapeutics and innovative health solutions. With a dedicated focus on research and development, Pacira BioSciences continues to lead the way in advancing non-opioid alternatives and enhancing the standard of care in pain management and regenerative health.

PCRX Revenue Chart

PCRX Earnings

Analyst Ratings